First In-Human Medical Imaging with a PASylated (89)Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer

PURPOSE: PASylation® offers the ability to systematically tune and optimize the pharmacokinetics of protein tracers for molecular imaging. Here we report the first clinical translation of a PASylated Fab fragment ((89)Zr∙Df-HER2-Fab-PAS(200)) for the molecular imaging of tumor-related HER2 expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Antonia, Knorr, Karina, Schlapschy, Martin, Robu, Stephanie, Morath, Volker, Mendler, Claudia, Yen, Hsi-Yu, Steiger, Katja, Kiechle, Marion, Weber, Wolfgang, Skerra, Arne, Schwaiger, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198682/
https://www.ncbi.nlm.nih.gov/pubmed/32377263
http://dx.doi.org/10.1007/s13139-020-00638-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198682/
https://www.ncbi.nlm.nih.gov/pubmed/32377263
http://dx.doi.org/10.1007/s13139-020-00638-7

Ejemplares similares